Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

17
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
17
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

1.3K
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.3K
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

1.6K
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
1.6K
Investigation of Disease Outbreaks01:23

Investigation of Disease Outbreaks

71
Multistate foodborne outbreaks pose significant public health risks and require meticulous investigation to identify sources and implement control measures. The Centers for Disease Control and Prevention (CDC) utilizes a dynamic seven-step process for these investigations, integrating data from laboratories, interviews, and environmental assessments to protect public health.Outbreak Detection: The detection of multistate outbreaks typically begins with PulseNet, the CDC's national laboratory...
71
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

1.3K
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
1.3K
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

1.6K
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Consensus statement of the Spanish Society of Neurology on the treatment of multiple sclerosis and holistic patient management in 2023.

Neurologia·2024
Same author

Epidemiology of ataxia and hereditary spastic paraplegia in Spain: A cross-sectional study.

Neurologia·2023
Same author

Epidemiology of ataxia and hereditary spastic paraplegia in Spain: a cross-sectional study.

Neurologia·2021
Same author

Facial variant of Guillain-Barré Syndrome in a patient, days after being vaccinated for influenza A.

Neurologia (Barcelona, Spain)·2010
Same author

[Non-compacted cardiomyopathy, presenting as repeated stroke].

Revista clinica espanola·2010
Same author

[Coma and respiratory insufficiency after fracture of femur and tibia].

Anales de medicina interna (Madrid, Spain : 1984)·2003
Same journal

[Amyotrophic neuralgia secondary to Vaxzevria (AstraZeneca) COVID-19 vaccine].

Neurologia (Barcelona, Spain)·2024
Same journal

[SARS-CoV-2 infection: Possible underdiagnosis of cerebral venous sinus thrombosis].

Neurologia (Barcelona, Spain)·2024
Same journal

[Bell's palsy following COVID-19 vaccination: A case report].

Neurologia (Barcelona, Spain)·2024
Same journal

[Parsonage-Turner syndrome post-infection by SARS-CoV-2: A case report].

Neurologia (Barcelona, Spain)·2024
Same journal

[Acute transverse myelitis following SARS-CoV-2 infection].

Neurologia (Barcelona, Spain)·2024
Same journal

[Neurological complications in critical patients with COVID-19].

Neurologia (Barcelona, Spain)·2024
See all related articles

Related Experiment Video

Updated: Apr 27, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.3K

Epidemiological study of multiple sclerosis in La Rioja.

M Bártulos Iglesias1, M E Marzo Sola2, L A Estrella Ruiz3

  • 1Asociación de Esclerosis Múltiple de La Rioja, Logroño, La Rioja, España; Sección de Neurología, Hospital Universitario de Burgos, Burgos, España.

Neurologia (Barcelona, Spain)
|July 1, 2014
PubMed
Summary
This summary is machine-generated.

This study reports multiple sclerosis (MS) prevalence in La Rioja, Spain, finding rates similar to other regions. Early-onset MS and aggressive disease in multiple-affected families require further investigation.

Keywords:
EpidemiologyEpidemiologíaEsclerosis múltipleEspañaIncidenceIncidenciaLa RiojaMultiple sclerosisPrevalencePrevalenciaSpain

More Related Videos

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
05:44

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice

Published on: October 13, 2023

2.6K
Hippocampal Neuronal Cultures to Detect and Study New Pathogenic Antibodies Involved in Autoimmune Encephalitis
08:20

Hippocampal Neuronal Cultures to Detect and Study New Pathogenic Antibodies Involved in Autoimmune Encephalitis

Published on: June 2, 2022

5.1K

Related Experiment Videos

Last Updated: Apr 27, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.3K
Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
05:44

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice

Published on: October 13, 2023

2.6K
Hippocampal Neuronal Cultures to Detect and Study New Pathogenic Antibodies Involved in Autoimmune Encephalitis
08:20

Hippocampal Neuronal Cultures to Detect and Study New Pathogenic Antibodies Involved in Autoimmune Encephalitis

Published on: June 2, 2022

5.1K

Area of Science:

  • Neurology
  • Epidemiology
  • Public Health

Background:

  • Multiple sclerosis (MS) is a debilitating demyelinating disease disproportionately affecting younger populations.
  • Epidemiological studies consistently show variable MS prevalence across different regions.
  • Understanding regional MS prevalence is crucial for resource allocation and public health strategies.

Purpose of the Study:

  • To determine the prevalence and incidence of multiple sclerosis (MS) in La Rioja, Spain.
  • To analyze MS patient data concerning age, sex, disease progression, and treatment.
  • To investigate associations with cancer history and familial MS occurrences.

Main Methods:

  • A 10-year retrospective analysis (2001-2011) of MS patients in La Rioja.
  • Data collection involved hospital records, MS associations, and neurologist-maintained patient data.
  • Diagnosis confirmation utilized Poser criteria or the 2005 McDonald criteria.

Main Results:

  • MS prevalence in La Rioja was 65/100,000 inhabitants, with an incidence of 3.5/100,000 annually.
  • Relapsing-remitting MS constituted 67.6% of cases, with a mean onset age of 20-29 years.
  • 47.6% of patients remained untreated; interferon was the most common disease-modifying therapy.

Conclusions:

  • MS prevalence and incidence in La Rioja align with national averages.
  • Primary progressive MS onset appears slightly later in this cohort compared to literature.
  • Familial MS cases may exhibit increased aggressiveness, underscoring the need for comprehensive epidemiological research.